Frank Staal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

PARIS, France, 12 October 2023 – Smart Immune, a clinical-stage biotechnology company developing ProTcell, a thymus-empowered T-cell progenitor therapy platform to fully and rapidly re-arm the immune system, announced today a series of activities in and around the European Society of Gene and Cell Therapy (ESGCT) 30th Annual Congress being held in Brussels, Belgium from October 24-27, 2023. Oral presentation by CSO ‘CAR ProTcell, towards well-tolerated and persistent off-the-shelf allogeneic CAR

Researchers from the Leiden University Medical Center (LUMC) have successfully used stem cell gene therapy to treat a baby with the severe congenital immune disorder SCID. An important milestone: it is the first time stem cell gene therapy of Dutch o

Share Researchers and clinicians at Leiden University Medical Centre (LUMC) are about to begin a milestone clinical study. It will be the first time a stem cell gene therapy developed in the Netherlands is used in a clinic. The therapy will be used to treat children with SCID, a rare disorder where children are born without essential immune cells. ‘We are the first group worldwide to have developed stem cell gene therapy for this type of SCID, RAG1-SCID to be precise. It is also the first stem cell gene therapy initiated by the Netherlands that will actually be used in patients,’ says Pro...